Surgical Science Sweden AB (publ) (SUSRF)
OTCMKTS
· Delayed Price · Currency is USD
15.50
0.00 (0.00%)
At close: May 21, 2025
SUSRF Revenue
Surgical Science Sweden AB had revenue of 250.69M SEK in the quarter ending March 31, 2025, with 33.17% growth. This brings the company's revenue in the last twelve months to 946.54M, up 12.41% year-over-year. In the year 2024, Surgical Science Sweden AB had annual revenue of 884.09M with 0.14% growth.
Revenue (ttm)
946.54M SEK
Revenue Growth
+12.41%
P/S Ratio
8.10
Revenue / Employee
3.45M SEK
Employees
274
Market Cap
763.54M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 884.09M | 1.23M | 0.14% |
Dec 31, 2023 | 882.85M | 80.31M | 10.01% |
Dec 31, 2022 | 802.54M | 435.76M | 118.81% |
Dec 31, 2021 | 366.78M | 261.98M | 249.98% |
Dec 31, 2020 | 104.80M | 3.28M | 3.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
American Oncology Network | 1.76B |